Raloxifene

BNF:
6.4.1
Status:
Green - after consultant initiation
Decision Date:
None
 

Comments

  • 60mg tablets
  • GREEN: as per NICE TA161 - see local osteoporosis guidance and NICE TA161
  • GREEN: as per NICE CG164 - 2nd line treatment for familial breast cancer; after consultant initiation used in postmenopausal women where tamoxifen is poorly tolerated or considered inappropriate, 5 year treatment course (decision date November 2013)

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app